HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses.

AbstractETHNOPHARMACOLOGICAL RELEVANCE AND AIM OF THE STUDY:
Tripterygium wilfordii (lei gong teng; Thunder of God Vine), a member of the Celastraceae family, is a medicinal plant used to treat a range of illnesses. Celastrol is a quinone methide triterpene and the most abundant bioactive constituent isolated from the root extracts of T. wilfordii. Previous studies have shown that celastrol exhibits antiviral activity against HIV and SARS-CoV. To date, no investigations of the anti-DENV activity of celastrol have been reported. This work aimed to investigate the anti-DENV effect and possible mechanism of celastrol in vitro and in vivo.
METHODS:
A four-serotype DENV infection system was performed to determine the anti-DENV effect of celastrol by detecting DENV RNA replication and protein synthesis. The precise anti-DENV replication mechanism of celastrol was clarified using specific RNA silencing and specific inhibitor. In addition, the therapeutic efficacy of celastrol was evaluated by monitoring survival rates and clinical scores in a DENV-infected Institute of Cancer Research (ICR) suckling mouse model.
RESULTS:
Celastrol inhibited DENV-1, -2, -3, and -4 RNA replication with EC50 values of 0.19 ± 0.09, 0.12 ± 0.11, 0.16 ± 0.14, and 0.17 ± 0.08 μM, respectively. This antiviral effect of celastrol was associated with celastrol-induced interferon-α (IFN-α) expression and was attenuated by a specific inhibitor of the JAK-STAT signaling pathway downstream of IFN-α or specific shRNA. Furthermore, celastrol protected ICR suckling mice against life-threatening DENV infection.
CONCLUSION:
Celastrol represents a potential anti-DENV agent that induces IFN-α expression and stimulates a downstream antiviral response, making the therapy a promising drug or dietary supplement for the treatment of DENV-infected patients.
AuthorsJung-Sheng Yu, Chin-Kai Tseng, Chun-Kuang Lin, Yao-Chin Hsu, Yu-Hsuan Wu, Ching-Liang Hsieh, Jin-Ching Lee
JournalAntiviral research (Antiviral Res) Vol. 137 Pg. 49-57 (01 2017) ISSN: 1872-9096 [Electronic] Netherlands
PMID27847245 (Publication Type: Journal Article)
CopyrightCopyright © 2016 Elsevier B.V. All rights reserved.
Chemical References
  • Antiviral Agents
  • Interferon Type I
  • Interferon-alpha
  • Pentacyclic Triterpenes
  • Triterpenes
  • celastrol
Topics
  • Animals
  • Animals, Suckling
  • Antiviral Agents (administration & dosage, pharmacology, therapeutic use)
  • DNA Replication (drug effects)
  • Dengue (drug therapy, virology)
  • Dengue Virus (drug effects, physiology)
  • Disease Models, Animal
  • Interferon Type I (genetics)
  • Interferon-alpha (genetics)
  • Mice
  • Mice, Inbred ICR
  • Pentacyclic Triterpenes
  • RNA Interference
  • Survival Analysis
  • Transcriptional Activation (drug effects)
  • Triterpenes (administration & dosage, pharmacology, therapeutic use)
  • Up-Regulation
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: